カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場予測2023-2029：CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他

【英語タイトル】Human Cytomegalovirus Envelope Glycoprotein B Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8775）・商品コード：MMG23LY8775
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：74
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模と予測を収録しています。・世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：売上、2018年-2023年、2024年-2029年
・世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「CSJ-148」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのグローバル主要企業は、Astellas Pharma Inc.、 Trellis Bioscience, Inc.、 Vakzine Projekt Management GmbH、 VBI Vaccine Inc、 Vical Incorporatedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：タイプ別市場シェア、2022年
・CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：用途別、2018年-2023年、2024年-2029年
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：用途別市場シェア、2022年
・感染症、腫瘍、ウィメンズヘルス、その他

世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒトサイトメガロウイルスエンベロープ糖タンパク質Bのグローバル売上、2018年-2023年
・主要企業におけるヒトサイトメガロウイルスエンベロープ糖タンパク質Bのグローバル売上シェア、2022年
・主要企業におけるヒトサイトメガロウイルスエンベロープ糖タンパク質Bのグローバル販売量、2018年-2023年
・主要企業におけるヒトサイトメガロウイルスエンベロープ糖タンパク質Bのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Astellas Pharma Inc.、 Trellis Bioscience, Inc.、 Vakzine Projekt Management GmbH、 VBI Vaccine Inc、 Vical Incorporated

*************************************************************

・調査・分析レポートの概要
ヒトサイトメガロウイルスエンベロープ糖タンパク質B市場の定義
市場セグメント
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模：2022年 VS 2029年
世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒトサイトメガロウイルスエンベロープ糖タンパク質Bの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒトサイトメガロウイルスエンベロープ糖タンパク質B製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他
ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：感染症、腫瘍、ウィメンズヘルス、その他
ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの用途別グローバル売上・予測

・地域別市場分析
地域別ヒトサイトメガロウイルスエンベロープ糖タンパク質B市場規模 2022年と2029年
地域別ヒトサイトメガロウイルスエンベロープ糖タンパク質B売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Astellas Pharma Inc.、 Trellis Bioscience, Inc.、 Vakzine Projekt Management GmbH、 VBI Vaccine Inc、 Vical Incorporated
...

This report aims to provide a comprehensive presentation of the global market for Human Cytomegalovirus Envelope Glycoprotein B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Cytomegalovirus Envelope Glycoprotein B. This report contains market size and forecasts of Human Cytomegalovirus Envelope Glycoprotein B in global, including the following market information:
Global Human Cytomegalovirus Envelope Glycoprotein B Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Cytomegalovirus Envelope Glycoprotein B Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Human Cytomegalovirus Envelope Glycoprotein B companies in 2022 (%)
The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
CSJ-148 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc and Vical Incorporated, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Cytomegalovirus Envelope Glycoprotein B manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Cytomegalovirus Envelope Glycoprotein B Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Human Cytomegalovirus Envelope Glycoprotein B Market Segment Percentages, by Type, 2022 (%)
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Global Human Cytomegalovirus Envelope Glycoprotein B Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Human Cytomegalovirus Envelope Glycoprotein B Market Segment Percentages, by Application, 2022 (%)
Infectious Disease
Oncology
Women’s Health
Others
Global Human Cytomegalovirus Envelope Glycoprotein B Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Human Cytomegalovirus Envelope Glycoprotein B Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Cytomegalovirus Envelope Glycoprotein B revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Cytomegalovirus Envelope Glycoprotein B revenues share in global market, 2022 (%)
Key companies Human Cytomegalovirus Envelope Glycoprotein B sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Human Cytomegalovirus Envelope Glycoprotein B sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Cytomegalovirus Envelope Glycoprotein B, market overview.
Chapter 2: Global Human Cytomegalovirus Envelope Glycoprotein B market size in revenue and volume.
Chapter 3: Detailed analysis of Human Cytomegalovirus Envelope Glycoprotein B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Cytomegalovirus Envelope Glycoprotein B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Cytomegalovirus Envelope Glycoprotein B capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Cytomegalovirus Envelope Glycoprotein B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Cytomegalovirus Envelope Glycoprotein B Overall Market Size
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size: 2022 VS 2029
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales: 2018-2029
3 Company Landscape
3.1 Top Human Cytomegalovirus Envelope Glycoprotein B Players in Global Market
3.2 Top Global Human Cytomegalovirus Envelope Glycoprotein B Companies Ranked by Revenue
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Companies
3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Companies
3.5 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Cytomegalovirus Envelope Glycoprotein B Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Cytomegalovirus Envelope Glycoprotein B Players in Global Market
3.8.1 List of Global Tier 1 Human Cytomegalovirus Envelope Glycoprotein B Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Cytomegalovirus Envelope Glycoprotein B Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Markets, 2022 & 2029
4.1.2 CSJ-148
4.1.3 CyMVectin
4.1.4 TRL-345
4.1.5 PPCM
4.1.6 Cytomegalovirus Vaccine
4.1.7 Others
4.2 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
4.2.1 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2023
4.2.2 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2024-2029
4.2.3 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
4.3 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
4.3.1 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2023
4.3.2 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2024-2029
4.3.3 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
4.4 By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2022 & 2029
5.1.2 Infectious Disease
5.1.3 Oncology
5.1.4 Women’s Health
5.1.5 Others
5.2 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
5.2.1 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2023
5.2.2 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2024-2029
5.2.3 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
5.3 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
5.3.1 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2023
5.3.2 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2024-2029
5.3.3 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
5.4 By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2022 & 2029
6.2 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue & Forecasts
6.2.1 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2023
6.2.2 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2024-2029
6.2.3 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
6.3 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Sales & Forecasts
6.3.1 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2023
6.3.2 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Sales, 2024-2029
6.3.3 By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029
6.4.2 By Country – North America Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2029
6.4.3 US Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.4.4 Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.4.5 Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029
6.5.2 By Country – Europe Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2029
6.5.3 Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.4 France Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.5 U.K. Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.6 Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.7 Russia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.8 Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.5.9 Benelux Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029
6.6.2 By Region – Asia Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2029
6.6.3 China Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.6.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.6.5 South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.6.6 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.6.7 India Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029
6.7.2 By Country – South America Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2029
6.7.3 Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.7.4 Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales, 2018-2029
6.8.3 Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.8.4 Israel Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.8.5 Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
6.8.6 UAE Human Cytomegalovirus Envelope Glycoprotein B Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Company Summary
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2018-2023)
7.1.5 Astellas Pharma Inc. Key News & Latest Developments
7.2 Trellis Bioscience, Inc.
7.2.1 Trellis Bioscience, Inc. Company Summary
7.2.2 Trellis Bioscience, Inc. Business Overview
7.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2018-2023)
7.2.5 Trellis Bioscience, Inc. Key News & Latest Developments
7.3 Vakzine Projekt Management GmbH
7.3.1 Vakzine Projekt Management GmbH Company Summary
7.3.2 Vakzine Projekt Management GmbH Business Overview
7.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2018-2023)
7.3.5 Vakzine Projekt Management GmbH Key News & Latest Developments
7.4 VBI Vaccine Inc
7.4.1 VBI Vaccine Inc Company Summary
7.4.2 VBI Vaccine Inc Business Overview
7.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2018-2023)
7.4.5 VBI Vaccine Inc Key News & Latest Developments
7.5 Vical Incorporated
7.5.1 Vical Incorporated Company Summary
7.5.2 Vical Incorporated Business Overview
7.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Major Product Offerings
7.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales and Revenue in Global (2018-2023)
7.5.5 Vical Incorporated Key News & Latest Developments
8 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity, Analysis
8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity, 2018-2029
8.2 Human Cytomegalovirus Envelope Glycoprotein B Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Cytomegalovirus Envelope Glycoprotein B Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Cytomegalovirus Envelope Glycoprotein B Supply Chain Analysis
10.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Value Chain
10.2 Human Cytomegalovirus Envelope Glycoprotein B Upstream Market
10.3 Human Cytomegalovirus Envelope Glycoprotein B Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Human Cytomegalovirus Envelope Glycoprotein B in Global Market
Table 2. Top Human Cytomegalovirus Envelope Glycoprotein B Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Companies, 2018-2023
Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Type
Table 9. List of Global Tier 1 Human Cytomegalovirus Envelope Glycoprotein B Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Cytomegalovirus Envelope Glycoprotein B Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2018-2023
Table 15. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2024-2029
Table 16. By Application – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2018-2023
Table 20. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2024-2029
Table 21. By Region – Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2018-2023
Table 25. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), 2024-2029
Table 26. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales, (K Pcs), 2024-2029
Table 46. Astellas Pharma Inc. Company Summary
Table 47. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offerings
Table 48. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Astellas Pharma Inc. Key News & Latest Developments
Table 50. Trellis Bioscience, Inc. Company Summary
Table 51. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offerings
Table 52. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Trellis Bioscience, Inc. Key News & Latest Developments
Table 54. Vakzine Projekt Management GmbH Company Summary
Table 55. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Offerings
Table 56. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Vakzine Projekt Management GmbH Key News & Latest Developments
Table 58. VBI Vaccine Inc Company Summary
Table 59. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Offerings
Table 60. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. VBI Vaccine Inc Key News & Latest Developments
Table 62. Vical Incorporated Company Summary
Table 63. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Offerings
Table 64. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Vical Incorporated Key News & Latest Developments
Table 66. Human Cytomegalovirus Envelope Glycoprotein B Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 67. Global Human Cytomegalovirus Envelope Glycoprotein B Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Human Cytomegalovirus Envelope Glycoprotein B Production by Region, 2018-2023 (K Pcs)
Table 69. Global Human Cytomegalovirus Envelope Glycoprotein B Production by Region, 2024-2029 (K Pcs)
Table 70. Human Cytomegalovirus Envelope Glycoprotein B Market Opportunities & Trends in Global Market
Table 71. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers in Global Market
Table 72. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints in Global Market
Table 73. Human Cytomegalovirus Envelope Glycoprotein B Raw Materials
Table 74. Human Cytomegalovirus Envelope Glycoprotein B Raw Materials Suppliers in Global Market
Table 75. Typical Human Cytomegalovirus Envelope Glycoprotein B Downstream
Table 76. Human Cytomegalovirus Envelope Glycoprotein B Downstream Clients in Global Market
Table 77. Human Cytomegalovirus Envelope Glycoprotein B Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Segment by Type in 2022
Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Segment by Application in 2022
Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Cytomegalovirus Envelope Glycoprotein B Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2022
Figure 9. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 23. US Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 28. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 37. China Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 44. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share, 2018-2029
Figure 48. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Human Cytomegalovirus Envelope Glycoprotein B by Region, 2022 VS 2029
Figure 54. Human Cytomegalovirus Envelope Glycoprotein B Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場予測2023-2029：CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他] (コード：MMG23LY8775)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場予測2023-2029：CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヒト注射用インフルエンザワクチン市場予測2023-2029：3価インフルエンザワクチン、4価インフルエンザワクチン
  • 世界のヒト用ワクチン接種市場予測2023-2029：不活化ワクチン、弱毒化生ワクチン、mRNAワクチン、結合型ワクチン、その他
  • 世界の10価肺炎球菌結合型ワクチン市場予測2023-2029：単回投与バイアル、プレフィルドシリンジ
  • 世界の帯状疱疹ワクチン市場予測2023-2029：生、組換え
  • 世界の小児用インフルエンザワクチン市場予測2023-2029：点鼻薬、注射

    • ◆H&Iグローバルリサーチのお客様（例）◆